Showing results (101-110 of 10,697) with videos related to
Sort By:
Pageof 1,070
Circulation. Heart Failure|September 8, 2020
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-Glucose Cotransporter 2) InhibitorsMilton PackerCirculation|March 14, 2020
Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient OverabundanceMilton PackerDiabetes, Obesity & Metabolism|February 23, 2018
Higher mortality rate in patients with heart failure who are taking commonly prescribed antidiabetic medications and achieve recommended levels of glycaemic controlMilton PackerClinical Ophthalmology (Auckland, N.Z.)|June 30, 2016
Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lensMark PackerAmerican Heart Journal|July 1, 1985
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestrationM PackerJournal of Cardiac Failure|August 2, 2017
Why Has a Run-In Period Been a Design Element in Most Landmark Clinical Trials? Analysis of the Critical Role of Run-In Periods in Drug DevelopmentMilton PackerNeuroscience and Biobehavioral Reviews|March 8, 2016
Neocortical neurogenesis and the etiology of autism spectrum disorderAlan PackerDiabetes, Obesity & Metabolism|December 12, 2017
Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetesMilton PackerCirculation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM PackerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2020
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia MimeticsMilton PackerPageof 1,070